Cytochrome P-450 arachidonate metabolite inhibition improves renal function in Lyon hypertensive rats

American Journal of Hypertension

Volumn 12, Issue 4 I, 1999, Pages 398-404

  Messer Létienne, Isabelle ^a   Bernard, Nicole ^a   Roman, Richard J ^b   Sassard, Jean ^a   Benzoni, Daniel ^a  

^a UNIVERSITÉ LYON 1   (France)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Arachidonic acid; Cytochrome P450; Hypertensive rat; Kidney

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; ENDOPEROXIDE; ICOSATRIENOIC ACID; KIDNEY ENZYME; MICONAZOLE; PROSTAGLANDIN H2; THROMBOXANE A2 RECEPTOR; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; VAPIPROST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DILATATION; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY METABOLISM; KIDNEY VASCULAR RESISTANCE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RENOVASCULAR HYPERTENSION; SODIUM URINE LEVEL;

ANIMALS; ARACHIDONIC ACID; BIPHENYL COMPOUNDS; CYTOCHROME P-450 ENZYME SYSTEM; HEMODYNAMIC PROCESSES; HEPTANOIC ACIDS; HYPERTENSION; KIDNEY; MALE; MICONAZOLE; NATRIURESIS; PERFUSION; PRESSURE; RATS; RECEPTORS, THROMBOXANE; REFERENCE VALUES;

EID: 0345643479     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00256-8     Document Type: Article

References (22)

1. Liu KL, Aissa AH, Laréal MC, et al: Adrenergic stimulation of renal prostanoids in the Lyon hypertensive rat. Hypertension 1991;17:296-302.
2. Liu KL, Benzoni D, Sassard J: Prostaglandin H2-thromboxane A2 and renal functions in the Lyon hypertensive rat. Am J Physiol 1994;266:R1530-R1536.
3. Liu KL, Sassard J, Benzoni D: In the Lyon hypertensive rat, renal function alterations are angiotensin II dependent. Am J Physiol 1996;271:R346-R351.
4. Schwartzman ML, Falck JR, Yadagiri P, Escalante B: Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. J Biol Chem 1989;264:11658-11662.
5. Imig JD, Navar LG, Roman RJ, et al: Actions of epoxygenase metabolites on the preglomerular vasculature. J Am Soc Nephrol 1996;7:2364-2370.
6. Imig JD, Zou AP, Stec DE, et al: Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol 1996;270:R217-R227.
7. Zou AP, Drummond HA, Roman RJ: Role of 20-HETE in elevating loop chloride reabsorption in Dahl SS/Jr rats. Hypertension 1996;217:631-635.
8. +-ATPase. J Clin Invest 1997;99:1224-1230.
9. Campbell WB, Gebremedhin D, Pratt PF, Harder DR: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Cire Res 1996;78: 415-423.
10. Caroll MA, Garcia MP, Falck JR, McGiff JC: 5,6-epoxyeicosatrienoic acid, a novel arachidonate metabolite. Cire Res 1990;67:1082-1088.
11. + channel activity. Am J Physiol 1996;270:F822-F832.
12. + channels in coronary smooth muscle through a guanine nucleotide binding protein. Circ Res 1997;80: 877-884.
13. Makita K, Takahashi K, Karara A, et al: Experimental and/or genetically controlled alterations of the renal microsomal cytochrome-P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 1994;94:2414-2420.
14. Takahashi K, Capdevila J, Karara A, et al: Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic responses. Am J Physiol 1990;258:F781-F789.
15. Katoh T, Takahashi K, Capdevila J, et al: Glomerular stereospecific synthesis and hemodynamic actions of 8,9-epoxyeicosatrienoic acid in rat kidney. Am J Physiol 1991;261:F578-F586.
16. Ma YH, Schwartzman ML, Roman RJ: Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. Am J Physiol 1994;267:R579-R589.
17. Imig JD, Falck JR, Gebremedhin D, et al: Elevated renovascular tone in young spontaneously hypertensive rats. Hypertension 1993;22:357-364.
18. Roman RJ, Cowley JR AW: Characterization of a new model for the study of pressure-natriuresis in the rat. Am J Physiol 1985;248:F190-F198.
19. Zou AP, Imig JD, Kaldunski M, et al: Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol 1994;266:F275-F282.
20. Lumley P, White BP, Humphrey PP: GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Br J Pharmacol 1989;97:783-794.
21. Welch WJ, Wilcox CS: Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa. J Clin Invest 1992;89:1857-1865.
22. Steinhilber D, Jaschonek K, Knospe J, et al: Effects of novel antifungal azole derivatives on the 5-lipoxygenase and cyclooxygenase pathway. Arzneim Forsch (Drug Res) 1990;40:1260-1263.